Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Jazz Pharmaceuticals ROE 2010-2024 | JAZZ

Current and historical return on equity (ROE) values for Jazz Pharmaceuticals (JAZZ) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
  
Jazz Pharmaceuticals ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2024-03-31 $0.36B $3.70B 9.83%
2023-12-31 $0.44B $3.74B 12.47%
2023-09-30 $0.08B $3.49B 2.35%
2023-06-30 $-0.09B $3.53B -2.77%
2023-03-31 $-0.16B $3.34B -5.08%
2022-12-31 $-0.22B $3.09B -7.09%
2022-09-30 $-0.02B $2.75B -0.53%
2022-06-30 $-0.05B $3.20B -1.39%
2022-03-31 $-0.45B $3.61B -11.48%
2021-12-31 $-0.33B $3.97B -8.31%
2021-09-30 $-0.16B $3.94B -4.15%
2021-06-30 $0.04B $4.13B 1.07%
2021-03-31 $0.52B $3.80B 14.82%
2020-12-31 $0.24B $3.66B 7.33%
2020-09-30 $0.18B $3.38B 5.76%
2020-06-30 $0.13B $3.14B 4.39%
2020-03-31 $0.28B $2.81B 9.37%
2019-12-31 $0.52B $3.11B 17.61%
2019-09-30 $0.61B $3.05B 21.10%
2019-06-30 $0.66B $2.98B 22.79%
2019-03-31 $0.49B $2.73B 17.04%
2018-12-31 $0.45B $2.76B 15.59%
2018-09-30 $0.52B $3.03B 18.22%
2018-06-30 $0.43B $2.87B 16.02%
2018-03-31 $0.45B $2.79B 17.62%
2017-12-31 $0.49B $2.71B 20.88%
2017-09-30 $0.37B $2.47B 17.54%
2017-06-30 $0.40B $2.20B 20.57%
2017-03-31 $0.41B $1.98B 22.51%
2016-12-31 $0.40B $1.88B 23.10%
2016-09-30 $0.36B $1.72B 22.01%
2016-06-30 $0.36B $1.69B 22.41%
2016-03-31 $0.34B $1.61B 21.56%
2015-12-31 $0.33B $1.60B 22.32%
2015-09-30 $0.33B $1.56B 23.14%
2015-06-30 $0.27B $1.45B 19.55%
2015-03-31 $0.22B $1.31B 16.84%
2014-12-31 $0.06B $1.37B 4.49%
2014-09-30 $0.03B $1.34B 2.47%
2014-06-30 $0.08B $1.28B 6.37%
2014-03-31 $0.08B $1.27B 6.34%
2013-12-31 $0.22B $1.30B 17.63%
2013-09-30 $0.36B $1.24B 30.71%
2013-06-30 $0.32B $1.18B 29.37%
2013-03-31 $0.30B $1.16B 30.40%
2012-12-31 $0.29B $1.12B 31.93%
2012-09-30 $0.13B $0.89B 18.57%
2012-06-30 $0.12B $0.83B 25.48%
2012-03-31 $0.13B $0.78B 42.69%
2011-12-31 $0.12B $0.19B 100.00%
2011-09-30 $0.11B $0.14B 132.93%
2011-06-30 $0.09B $0.10B 191.67%
2011-03-31 $0.05B $0.06B 286.49%
2010-12-31 $0.03B $0.03B -232.73%
2010-09-30 $0.01B $-0.00B -35.22%
2010-06-30 $-0.00B $-0.02B 1.67%
2010-03-31 $0.01B $-0.07B -8.95%
2009-12-31 $-0.01B $-0.07B 8.33%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $6.731B $3.834B
Jazz Pharmaceuticals is a specialty biopharmaceutical company with a focus in the areas of neuroscience & oncology. It derives the majority of its revenues from its sleep disorder drugs' Xywav & Xyrem. Both drugs are approved for treating cataplexy & excessive daytime sleepiness in narcolepsy patients. Other drugs in the company's neuroscience portfolio include' Sunosi, Epidiolex & Sativex. Epidiolex is approved for treating seizures associated with two rare & severe forms of epilepsy' Lennox-Gastaut syndrome & Dravet syndrome. Sativex is approved in the U.K. & Canada as a treatment for symptom improvement in adult patients with moderate-to-severe spasticity due to multiple sclerosis. Jazz's oncology portfolio includes two drugs' Defitelio for the treatment hepatic veno-occlusive disease with renal or pulmonary dysfunction following hematopoietic stem cell transplantation & Vyxeos for the treatment of adults with two types of acute myeloid leukemia. It received approval for two new drugs' Zepzelca & Rylaze'.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $79.103B 32.16
Chugai Pharmaceutical (CHGCY) Japan $58.463B 26.13
Takeda Pharmaceutical (TAK) Japan $40.953B 8.29
Merck (MKGAF) Germany $21.654B 21.00
Astellas Pharma (ALPMY) Japan $17.843B 28.17
Sandoz Group AG (SDZNY) Switzerland $15.602B 0.00
United Therapeutics (UTHR) United States $14.130B 15.06
Neurocrine Biosciences (NBIX) United States $13.855B 37.93
Shionogi (SGIOY) Japan $11.518B 10.01
Catalent (CTLT) United States $10.177B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.450B 0.00
Ionis Pharmaceuticals (IONS) United States $6.957B 0.00
Revolution Medicines (RVMD) United States $6.403B 0.00
Orion OYJ (ORINY) Finland $6.014B 25.36
Madrigal Pharmaceuticals (MDGL) United States $5.971B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.561B 0.00
Summit Therapeutics (SMMT) United States $5.475B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.532B 0.00
Corcept Therapeutics (CORT) United States $3.383B 30.65
Arrowhead Pharmaceuticals (ARWR) United States $3.228B 0.00
Dyne Therapeutics (DYN) United States $3.084B 0.00
PTC Therapeutics (PTCT) United States $2.345B 0.00
Indivior (INDV) United States $2.223B 10.54
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.960B 11.14
Catalyst Pharmaceuticals (CPRX) United States $1.830B 17.81
Recursion Pharmaceuticals (RXRX) United States $1.782B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.728B 0.00
Ardelyx (ARDX) United States $1.724B 0.00
Evotec AG (EVO) Germany $1.701B 0.00
Soleno Therapeutics (SLNO) United States $1.363B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.351B 0.00
Pacira BioSciences (PCRX) United States $1.332B 12.66
BioCryst Pharmaceuticals (BCRX) United States $1.275B 0.00
Xencor (XNCR) United States $1.167B 0.00
Calliditas Therapeutics AB (CALT) Sweden $1.162B 0.00
Enliven Therapeutics (ELVN) United States $1.099B 0.00
4D Molecular Therapeutics (FDMT) United States $1.085B 0.00
Ocular Therapeutix (OCUL) United States $1.059B 0.00
Collegium Pharmaceutical (COLL) United States $1.053B 6.30
Ironwood Pharmaceuticals (IRWD) United States $1.021B 15.90
Centessa Pharmaceuticals (CNTA) United Kingdom $0.907B 0.00
Cronos Group (CRON) Canada $0.891B 0.00
Relay Therapeutics (RLAY) United States $0.865B 0.00
USANA Health Sciences (USNA) United States $0.862B 14.09
ARS Pharmaceuticals (SPRY) United States $0.825B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.815B 0.00
Harrow (HROW) United States $0.739B 0.00
Sage Therapeutics (SAGE) United States $0.654B 0.00
Exscientia (EXAI) United Kingdom $0.617B 0.00
Cassava Sciences (SAVA) United States $0.593B 0.00
Silence Therapeutics (SLN) United Kingdom $0.569B 0.00
ProKidney (PROK) United States $0.564B 0.00
Savara (SVRA) United States $0.557B 0.00
Siga Technologies (SIGA) United States $0.540B 6.90
Lexeo Therapeutics (LXEO) United States $0.528B 0.00
Heron Therapeutics (HRTX) United States $0.527B 0.00
KalVista Pharmaceuticals (KALV) United States $0.497B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.484B 0.00
Altimmune (ALT) United States $0.472B 0.00
Larimar Therapeutics (LRMR) United States $0.463B 0.00
Bioventus (BVS) United States $0.455B 17.42
OmniAb (OABI) United States $0.441B 0.00
Esperion Therapeutics (ESPR) United States $0.421B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.412B 0.00
Verve Therapeutics (VERV) United States $0.410B 0.00
Organogenesis (ORGO) United States $0.371B 70.00
Lyell Immunopharma (LYEL) United States $0.370B 0.00
Xeris Biopharma Holdings (XERS) United States $0.334B 0.00
Tourmaline Bio (TRML) United States $0.330B 0.00
Korro Bio (KRRO) United States $0.314B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.309B 0.00
Nature's Sunshine Products (NATR) United States $0.282B 17.94
Enanta Pharmaceuticals (ENTA) United States $0.275B 0.00
Black Diamond Therapeutics (BDTX) United States $0.262B 0.00
Foghorn Therapeutics (FHTX) United States $0.245B 0.00
Aquestive Therapeutics (AQST) United States $0.237B 0.00
Nanobiotix S.A (NBTX) France $0.236B 0.00
ESSA Pharma (EPIX) Canada $0.233B 0.00
Nektar Therapeutics (NKTR) United States $0.228B 0.00
Century Therapeutics (IPSC) United States $0.215B 0.00
Akebia Therapeutics (AKBA) United States $0.214B 0.00
Elite Pharmaceuticals (ELTP) United States $0.213B 19.90
Eliem Therapeutics (ELYM) United States $0.212B 0.00
Prelude Therapeutics (PRLD) United States $0.209B 0.00
Profound Medical (PROF) Canada $0.205B 0.00
Zevra Therapeutics (ZVRA) United States $0.205B 0.00
Fractyl Health (GUTS) United States $0.205B 0.00
Avita Medical (RCEL) United States $0.204B 0.00
Innate Pharma SA (IPHYF) France $0.200B 0.00
Aldeyra Therapeutics (ALDX) United States $0.197B 0.00
Pyxis Oncology (PYXS) United States $0.195B 0.00
Incannex Healthcare (IXHL) Australia $0.187B 0.00
Acrivon Therapeutics (ACRV) United States $0.179B 0.00
Achieve Life Sciences (ACHV) Canada $0.161B 0.00
Metagenomi (MGX) United States $0.153B 0.00
Context Therapeutics (CNTX) United States $0.150B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.144B 0.00
MediWound (MDWD) Israel $0.144B 0.00
Telomir Pharmaceuticals (TELO) United States $0.142B 0.00
Galectin Therapeutics (GALT) United States $0.140B 0.00
Cardiol Therapeutics (CRDL) Canada $0.139B 0.00
CytoDyn (CYDY) United States $0.138B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.129B 8.64
VAXART, INC (VXRT) United States $0.118B 0.00
Assertio Holdings (ASRT) United States $0.118B 5.39
OptiNose (OPTN) United States $0.118B 0.00
Regulus Therapeutics (RGLS) United States $0.117B 0.00
Journey Medical (DERM) United States $0.113B 0.00
Karyopharm Therapeutics (KPTI) United States $0.108B 0.00
Citius Pharmaceuticals (CTXR) United States $0.105B 0.00
Relmada Therapeutics (RLMD) United States $0.091B 0.00
FibroGen (FGEN) United States $0.089B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.086B 0.00
PMV Pharmaceuticals (PMVP) United States $0.083B 0.00
AlloVir (ALVR) United States $0.083B 0.00
ProPhase Labs (PRPH) United States $0.080B 0.00
Aclaris Therapeutics (ACRS) United States $0.078B 0.00
Conduit Pharmaceuticals (CDT) United States $0.078B 0.00
Arch Biopartners (ACHFF) Canada $0.078B 0.00
SCYNEXIS (SCYX) United States $0.076B 1.06
CASI Pharmaceuticals (CASI) China $0.074B 0.00
Champions Oncology (CSBR) United States $0.070B 0.00
Vivani Medical (VANI) United States $0.069B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.064B 0.00
Carisma Therapeutics (CARM) United States $0.063B 0.00
Nutriband (NTRB) United States $0.060B 0.00
Mural Oncology (MURA) Ireland $0.053B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.050B 0.00
Tempest Therapeutics (TPST) United States $0.049B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.048B 0.00
BioLineRx (BLRX) Israel $0.046B 0.00
Lipocine (LPCN) United States $0.044B 0.00
Inotiv (NOTV) United States $0.043B 0.00
Protara Therapeutics (TARA) United States $0.043B 0.00
DURECT (DRRX) United States $0.040B 0.00
ElectroCore (ECOR) United States $0.039B 0.00
Natural Alternatives (NAII) United States $0.037B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.036B 0.00
Rafael Holdings (RFL) United States $0.035B 0.00
Surrozen (SRZN) United States $0.035B 0.00
Enlivex Therapeutics (ENLV) Israel $0.030B 0.00
VYNE Therapeutics (VYNE) United States $0.029B 0.00
NRx Pharmaceuticals (NRXP) United States $0.026B 0.00
BioVie (BIVI) United States $0.025B 0.00
Gain Therapeutics (GANX) United States $0.023B 0.00
Aptorum Group (APM) United Kingdom $0.023B 0.00
Oncternal Therapeutics (ONCT) United States $0.022B 0.00
Minerva Neurosciences (NERV) United States $0.022B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.022B 0.00
Viracta Therapeutics (VIRX) United States $0.021B 0.00
PolyPid (PYPD) Israel $0.021B 0.00
JanOne (JAN) United States $0.020B 0.00
MEI Pharma (MEIP) United States $0.019B 0.74
Iterum Therapeutics (ITRM) Ireland $0.019B 0.00
Unicycive Therapeutics (UNCY) United States $0.019B 0.00
TherapeuticsMD (TXMD) United States $0.019B 0.00
GlycoMimetics (GLYC) United States $0.018B 0.00
Indaptus Therapeutics (INDP) United States $0.018B 0.00
Cosmos Health (COSM) Greece $0.018B 0.00
Jaguar Animal Health (JAGX) United States $0.018B 0.00
Lyra Therapeutics (LYRA) United States $0.017B 0.00
SHINECO (SISI) China $0.017B 0.00
Nuvilex (PMCB) United States $0.017B 0.00
Talphera (TLPH) United States $0.015B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.013B 0.00
Avalo Therapeutics (AVTX) United States $0.013B 0.00
Mannatech (MTEX) United States $0.013B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.012B 0.00
Traws Pharma (TRAW) United States $0.011B 0.00
Alaunos Therapeutics (TCRT) United States $0.011B 0.00
Dominari Holdings (DOMH) United States $0.011B 0.00
Redhill Biopharma (RDHL) Israel $0.011B 0.00
Universe Pharmaceuticals INC (UPC) China $0.009B 0.00
Inhibikase Therapeutics (IKT) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Plus Therapeutics (PSTV) United States $0.008B 0.00
Molecular Templates (MTEM) United States $0.008B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
Biomerica (BMRA) United States $0.007B 0.00
Vivos Therapeutics (VVOS) United States $0.007B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.007B 0.00
TransCode Therapeutics (RNAZ) United States $0.007B 0.00
Heatwurx (PCSA) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Ainos (AIMD) United States $0.005B 0.00
CERo Therapeutics Holdings (CERO) United States $0.005B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.004B 0.00
Bio-Path Holdings (BPTH) United States $0.004B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Avenue Therapeutics (ATXI) United States $0.003B 0.00
Petros Pharmaceuticals (PTPI) United States $0.003B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Clearmind Medicine (CMND) Canada $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.001B 0.00
Qualigen Therapeutics (QLGN) United States $0.001B 0.00
PainReform (PRFX) Israel $0.001B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Aditxt (ADTX) United States $0.000B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 4.83
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 31.08